Functional, Diagnostic and Therapeutic Aspects of Bile

References

• Boyer JL. Bile Formation and Cholestasis. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff’s Diseases of the Liver. Philadelphia: Lippincott, Williams & Wilkins; 2002:135–165.
   Google Scholar
• Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65(16):2461–2483. PMID: 18488143. doi:10.1007/s00018-008-7568-6
   PubMed Web of Science ®Google Scholar
• Chen I, Cassaro S. Physiology, bile acids. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 31747172.
   Google Scholar
• Chiang JY. Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases. Hepatology. 2015;62(4):1315–1317. PMID: 26122550; PMCID: PMC4589461. doi:10.1002/hep.27964
   PubMed Web of Science ®Google Scholar
• Nagana Gowda GA, Shanaiah N, Cooper A, Maluccio M, Raftery D. Bile acids conjugation in human bile is not random: new insights from (1) H-NMRspectroscopy at 800 MHz. Lipids. 2009;44(6):527–535. PMID: 19373503; PMCID: PMC5459358. doi:10.1007/s11745-009-3296-4
   PubMed Web of Science ®Google Scholar
• Carey MC, Small DM. Micelle formation by bile salts. Physical-chemical and thermodynamic considerations. Arch Intern Med. 1972;130(4):506–527. PMID: 4562149. doi:10.1001/archinte.1972.03650040040005
   PubMedGoogle Scholar
• Di Ciaula A, Garruti G, Lunardi Baccetto R, et al. Bile acid physiology. Ann Hepatol. 2017;16:s4–s14. PMID: 29080336. doi:10.5604/01.3001.0010.5493
   PubMed Web of Science ®Google Scholar
• Kojima T, Yamamoto T, Murata M, Chiba H, Kokai Y, Sawada N. Regulation of the blood-biliary barrier: interaction between gap and tight junctions in hepatocytes. Med Electron Microsc. 2003;36(3):157–164. PMID: 14505059. doi:10.1007/s00795-003-0220-5
   PubMedGoogle Scholar
• Reshetnyak VI. Physiological and molecular biochemical mechanisms of bile formation. World J Gastroenterol. 2013;19(42):7341–7360. PMID: 24259965; PMCID: PMC3831216. doi:10.3748/wjg.v19.i42.7341
   PubMed Web of Science ®Google Scholar
• Almajid AN, Sugumar K. Physiology, bile. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Jazrawi RP, Pazzi P, Petroni ML, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology. 1995;109(2):582–591. PMID: 7615209. doi:10.1016/0016-5085(95)90348-8
   PubMed Web of Science ®Google Scholar
• Banales JM, Prieto J, Medina JF. Cholangiocyte anion exchange and biliary bicarbonate excretion. World J Gastroenterol. 2006;12(22):3496–3511. PMID: 16773707; PMCID: PMC4087566. doi:10.3748/wjg.v12.i22.3496
   PubMed Web of Science ®Google Scholar
• Kaminski DL, Nahrwold DL. Neurohormonal control of biliary secretion and gallbladder function. World J Surg. 1979;3(4):449–456. PMID: 516757. doi:10.1007/BF01556105
   PubMedGoogle Scholar
• Hundt M, Basit H, John S. physiology, bile secretion. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 29262229.
   Google Scholar
• Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009;50(12):2340–2357. PMID: 19498215; PMCID: PMC2781307. doi:10.1194/jlr.R900012-JLR200
   PubMed Web of Science ®Google Scholar
• Cai JS, Chen JH. The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol. 2014;247(11):1067–1082. PMID: 25107305; PMCID: PMC4207937. doi:10.1007/s00232-014-9715-3
   PubMed Web of Science ®Google Scholar
• Fujino T, Une M, Imanaka T, Inoue K, Nishimaki-Mogami T. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J Lipid Res. 2004;45(1):132–138. PMID: 13130122. doi:10.1194/jlr.M300215-JLR200
   PubMed Web of Science ®Google Scholar
• Beuers U, Trauner M, Jansen P, Poupon R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol. 2015;62(1Suppl):S25–37. PMID: 25920087. doi:10.1016/j.jhep.2015.02.023
   PubMed Web of Science ®Google Scholar
• Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. Intestinal absorption of bile acids in health and disease. Compr Physiol. 2019;10(1):21–56. PMID: 31853951; PMCID: PMC7171925. doi:10.1002/cphy.c190007
   PubMed Web of Science ®Google Scholar
• Lee JM, Ong JR, Vergnes L, et al. Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. J Lipid Res. 2018;59(3):429–438. PMID: 29295820; PMCID: PMC5832924. doi:10.1194/jlr.M078279
   PubMed Web of Science ®Google Scholar
• Mencarelli A, Fiorucci S. FXR an emerging therapeutic target for the treatment of atherosclerosis. J Cell Mol Med. 2010;14(1–2):79–92. PMID: 20041971; PMCID: PMC3837604. doi:10.1111/j.1582-4934.2009.00997.x
   PubMed Web of Science ®Google Scholar
• Wang X, Fu X, Van Ness C, Meng Z, Ma X, Huang W. Bile acid receptors and liver cancer. Curr Pathobiol Rep. 2013;1(1):29–35. PMID: 23420103; PMCID: PMC3571718. doi:10.1007/s40139-012-0003-6
   PubMedGoogle Scholar
• Kumar DP, Rajagopal S, Mahavadi S, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun. 2012;427(3):600–605. PMID: 23022524; PMCID: PMC3498511. doi:10.1016/j.bbrc.2012.09.104
   PubMed Web of Science ®Google Scholar
• Lavoie B, Balemba OB, Godfrey C, et al. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol. 2010;588(Pt17):3295–3305. PMID: 20624794; PMCID: PMC2976023. doi:10.1113/jphysiol.2010.192146
   PubMed Web of Science ®Google Scholar
• Keitel V, Reinehr R, Gatsios P, et al. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology. 2007;45(3):695–704. PMID: 17326144. doi:10.1002/hep.21458
   PubMed Web of Science ®Google Scholar
• Reich M, Klindt C, Deutschmann K, Spomer L, Häussinger D, Keitel V. Role of the G Protein-coupled bile acid receptor TGR5 in liver damage. Dig Dis. 2017;35(3):235–240. PMID: 28249265. doi:10.1159/000450917
   PubMed Web of Science ®Google Scholar
• Donepudi AC, Boehme S, Li F, Chiang JY. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology. 2017;65(3):813–827. PMID: 27351453; PMCID: PMC5195921. doi:10.1002/hep.28707
   PubMed Web of Science ®Google Scholar
• Tripathi N, Jialal I. Conjugated hyperbilirubinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32965843.
   Google Scholar
• Angelin B, Björkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids in man. fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest. 1982;70(4):724–731. PMID: 7119112; PMCID: PMC370280. doi:10.1172/jci110668
   PubMed Web of Science ®Google Scholar
• Craddock AL, Love MW, Daniel RW, et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998;274(1):G157–69. PMID: 9458785. doi:10.1152/ajpgi.1998.274.1.G157
   PubMed Web of Science ®Google Scholar
• Ballatori N, Christian WV, Lee JY, et al. OSTα-OSTβ: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology. 2005;42(6):1270–1279. doi:10.1002/hep.20961
   PubMed Web of Science ®Google Scholar
• Cao R, Cronk ZX, Zha W, et al. Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G (alpha) i-protein-coupled receptors and the AKT pathway. J Lipid Res. 2010;51(8):2234–2244. PMID: 20305288; PMCID: PMC2903791. doi:10.1194/jlr.M004929
   PubMed Web of Science ®Google Scholar
• Hoffmann AF, Borgstroem B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest. 1964;43(2):247–257. PMID: 14162533; PMCID: PMC289518. doi:10.1172/JCI104909
   PubMed Web of Science ®Google Scholar
• Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and long term effects in the intestine. Scand J Gastroenterol. 2010;45(6):645–664. PMID: 20334475. doi:10.3109/00365521003702734
   PubMed Web of Science ®Google Scholar
• Sannasiddappa TH, Lund PA, Clarke SR. In vitro antibacterial activity of unconjugated and conjugated bile salts on Staphylococcus aureus. Front Microbiol. 2017;8:1581. PMID: 28878747; PMCID: PMC5572772. doi:10.3389/fmicb.2017.01581
   PubMed Web of Science ®Google Scholar
• Neale G, Lewis B, Weaver V, Panveliwalla D. Serum bile acids in liver disease. Gut. 1971;12(2):145–152. PMID: 5548561; PMCID: PMC1411536. doi:10.1136/gut.12.2.145
   PubMed Web of Science ®Google Scholar
• Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses. 1986;19(1):57–69. PMID: 2871479. doi:10.1016/0306-9877(86)90137-4
   PubMed Web of Science ®Google Scholar
• Mannes GA, Stellaard F, Paumgartner G. Increased serum bile acids in cirrhosis with normal transaminases. Digestion. 1982;25(4):217–221. PMID: 7166204. doi:10.1159/000198835
   PubMed Web of Science ®Google Scholar
• Grundy SM, Metzger AL, Adler RD. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest. 1972;51(12):3026–3043. PMID: 4640946; PMCID: PMC332985. doi:10.1172/JCI107130
   PubMed Web of Science ®Google Scholar
• Barrera F, Azócar L, Molina H, et al. Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19. Ann Hepatol. 2015;14(5):710–721. PMID: 26256900. doi:10.1016/S1665-2681(19)30766-5
   PubMed Web of Science ®Google Scholar
• Berr F, Stellaard F, Pratschke E, Paumgartner G. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest. 1989;83(5):1541–1550. PMID: 2708522; PMCID: PMC303859. doi:10.1172/JCI114050
   PubMed Web of Science ®Google Scholar
• Fort JM, Azpiroz F, Casellas F, Andreu J, Malagelada JR. Bowel habit after cholecystectomy: physiological changes and clinical implications. Gastroenterology. 1996;111(3):617–622. PMID: 8780565. doi:10.1053/gast.1996.v111.pm8780565
   PubMed Web of Science ®Google Scholar
• O’Donnell LJ. Post-cholecystectomy diarrhoea: a running commentary. Gut. 1999;45(6):796–797. PMID: 10562574; PMCID: PMC1727755. doi:10.1136/gut.45.6.796
   PubMed Web of Science ®Google Scholar
• Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12(1):1–16. PMID: 28498901. doi:10.1093/ecco-jcc/jjx061
   PubMed Web of Science ®Google Scholar
• Kouker G, Jaeger KE. Specific and sensitive plate assay for bacterial lipases. Appl Environ Microbiol. 1987;53(1):211–213. PMID: 3103532; PMCID: PMC203632. doi:10.1128/aem.53.1.211-213.1987
   PubMed Web of Science ®Google Scholar
• Steiner MS, Morton RA. Nutritional and gastrointestinal complications of the use of bowel segments in the lower urinary tract. Urol Clin North Am. 1991;18(4):743–754. PMID: 1949406. doi:10.1016/S0094-0143(21)00375-X
   PubMed Web of Science ®Google Scholar
• Lapidus A, Akerlund JE, Einarsson C. Gallbladder bile composition in patients with Crohn ‘s disease. World J Gastroenterol. 2006;12(1):70–74. PMID: 16440420; PMCID: PMC4077498. doi:10.3748/wjg.v12.i1.70
   PubMed Web of Science ®Google Scholar
• Gregory JG, Park KY, Schoenberg HW. Oxalate stone disease after intestinal resection. J Urol. 1977;117(5):631–634. PMID: 870715. doi:10.1016/s0022-5347(17)58564-x
   PubMed Web of Science ®Google Scholar
• Sobala GM, O’Connor HJ, Dewar EP, King RF, Axon AT, Dixon MF. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol. 1993;46(3):235–240. PMID: 8463417; PMCID: PMC501177. doi:10.1136/jcp.46.3.235
   PubMed Web of Science ®Google Scholar
• Fracchia M, Pellegrino S, Secreto P, et al. Biliary bile acid composition in gastric cancer. Int J Clin Lab Res. 1999;29(1):46–48. PMID: 10356664. doi:10.1007/s005990050062
   PubMedGoogle Scholar
• Mabrut JY, Collard JM, Baulieux J. Le reflux biliaire duodéno-gastrique et gastro-oesophagien [Duodenogastric and gastroesophageal bile reflux]. J Chir. 2006. 143(6):355–365. French. PMID: 17285081. doi:10.1016/s0021-7697(06)73717-6
   PubMedGoogle Scholar
• Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol. 1994;267(6 Pt 1):G1050–7. PMID: 7810652. doi:10.1152/ajpgi.1994.267.6.G1050
   PubMed Web of Science ®Google Scholar
• Gillen P, Keeling P, Byrne PJ, Healy M, O’Moore RR, Hennessy TP. Implication of duodenogastric reflux in the pathogenesis of Barrett’s oesophagus. Br J Surg. 1988;75(6):540–543. PMID: 3395818. doi:10.1002/bjs.1800750612
   PubMed Web of Science ®Google Scholar
• Liu R, Li X, Hylemon PB, Zhou H. Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and cancer stem cell expansion via sphingosine 1-phosphate receptor 2-mediated yes-associated protein activation. Am J Pathol. 2018;188(9):2042–2058. PMID: 29963993; PMCID: PMC6105923. doi:10.1016/j.ajpath.2018.05.015
   PubMed Web of Science ®Google Scholar
• Vaezi MF, Richter JE. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice. Hepatogastroenterology. 1999;46(25):40–47. PMID: 10228763.
   PubMedGoogle Scholar
• Strignano P, Collard JM, Michel JM, et al. Duodenal switch operation for pathologic transpyloric duodenogastric reflux. Ann Surg. 2007;245(2):247–253. PMID: 17245178; PMCID: PMC1876986. doi:10.1097/01.sla.0000242714.59254.0e
   PubMed Web of Science ®Google Scholar
• Sifrim D. Management of bile reflux. Gastroenterol Hepatol. 2013;9(3):179–180. PMID: 23961269; PMCID: PMC3745208.
   Google Scholar
• Li T, Apte U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv Pharmacol. 2015;74:263–302. PMID: 26233910; PMCID: PMC4615692. doi:10.1016/bs.apha.2015.04.003
   PubMedGoogle Scholar
• Stepien M, Lopez-Nogueroles M, Lahoz A, et al. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma. Int J Cancer. 2021;148:609–625. PMID: 34843121. doi:10.1002/ijc.33885
   PubMed Web of Science ®Google Scholar
• Wang Y, Aoki H, Yang J, et al. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Hepatology. 2017;65(6):2005–2018. PMID: 28120434; PMCID: PMC5444993. doi:10.1002/hep.29076
   PubMed Web of Science ®Google Scholar
• Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015;9(3):332–339. PMID: 25918262; PMCID: PMC4413966. doi:10.5009/gnl14397
   PubMed Web of Science ®Google Scholar
• Walters JRF, Arasaradnam R, Andreyev HJN; UK Bile Acid Related Diarrhoea Network. Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice. Frontline Gastroenterol. 2019;11(5):358–363. PMID: 32879719; PMCID: PMC7447276. doi:10.1136/flgastro-2019-101301
   PubMed Web of Science ®Google Scholar
• Walters JR, Pattni SS. Managing bile acid diarrhoea. Therap Adv Gastroenterol. 2010;3(6):349–357. PMID: 21180614; PMCID: PMC3002596. doi:10.1177/1756283X10377126
   PubMedGoogle Scholar
• Barkun AN, Love J, Gould M, Pluta H, Steinhart H. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol. 2013;27(11):653–659. PMID: 24199211; PMCID: PMC3816948. doi:10.1155/2013/485631
   PubMed Web of Science ®Google Scholar
• Wildt S, Nørby Rasmussen S, Lysgård Madsen J, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand J Gastroenterol. 2003;38(8):826–830. PMID: 12940434. doi:10.1080/00365520310004461
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet Med. 1998;15(8):651–656. PMID: 9702467. doi:10.1002/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol. 2013;11(10):1232–1239. PMID: 23644387; PMCID: PMC3783593. doi:10.1016/j.cgh.2013.04.029
   PubMed Web of Science ®Google Scholar
• Gälman C, Arvidsson I, Angelin B, Rudling M. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res. 2003;44(4):859–866. PMID: 12562858. doi:10.1194/jlr.D200043-JLR200
   PubMed Web of Science ®Google Scholar
• Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009;21(7):734–e43. PMID: 19368662; PMCID: PMC2705747. doi:10.1111/j.1365-2982.2009.01288.x
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Chedid V, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol. 2019;17(5):922–929.e2. PMID: 29902647; PMCID: PMC6291372. doi:10.1016/j.cgh.2018.05.050
   PubMed Web of Science ®Google Scholar
• Walters JR. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2014;11(7):426–434. PMID: 24662279. doi:10.1038/nrgastro.2014.32
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Carlson P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther. 2017;46(6):581–588. PMID: 28691284; PMCID: PMC5555810. doi:10.1111/apt.14214
   PubMed Web of Science ®Google Scholar
• Hvas CL, Ott P, Paine P, Lal S, Jørgensen SP, Dahlerup JF. Obeticholic acid for severe bile acid diarrhea with intestinal failure: a case report and review of the literature. World J Gastroenterol. 2018;24(21):2320–2326. PMID: 29881241; PMCID: PMC5989246. doi:10.3748/wjg.v24.i21.2320
   PubMed Web of Science ®Google Scholar
• Kårhus ML, Brønden A, Røder ME, Leotta S, Sonne DP, Knop FK. Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide. Gastroenterology. 2019;157(2):569–571. PMID: 30965026. doi:10.1053/j.gastro.2019.04.002
   PubMed Web of Science ®Google Scholar
• Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut. 2004;53(1):78–84. PMID: 14684580; PMCID: PMC1773940. doi:10.1136/gut.53.1.78
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Ung TT, Kim NH, Jung YD. Role of bile acids in colon carcinogenesis. World J Clin Cases. 2018;6(13):577–588. PMID: 30430113; PMCID: PMC6232560. doi:10.12998/wjcc.v6.i13.577
   PubMed Web of Science ®Google Scholar
• Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch Dermatol. 2007;143(6):757–762. PMID: 17576942. doi:10.1001/archderm.143.6.757
   PubMedGoogle Scholar
• Anwer MS, Meyer DJ. Bile acids in the diagnosis, pathology, and therapy of hepatobiliary diseases. Vet Clin North Am Small Anim Pract. 1995;25(2):503–517. PMID: 7785176. doi:10.1016/s0195-5616(95)50039-7
   PubMed Web of Science ®Google Scholar
• Schwarz HP, Paumgartner G, Preisig R. Diagnostische Bedeutung der Serumgallensäuren [Diagnostic significance of serum bile acids]. Schweiz Med Wochenschr. 1975;105(17):533–535. German. PMID: 1153981.
   PubMedGoogle Scholar
• Liu N, Feng J, Lv Y, et al. Role of bile acids in the diagnosis and progression of liver cirrhosis: a prospective observational study. Exp Ther Med. 2019;18(5):4058–4066. PMID: 31611941; PMCID: PMC6781791. doi:10.3892/etm.2019.8011
   PubMed Web of Science ®Google Scholar
• Thomas CE, Luu HN, Wang R, et al. Association between pre-diagnostic serum bile acids and hepatocellular carcinoma: the Singapore Chinese health study. Cancers. 2021;13(11):2648. PMID: 34071196; PMCID: PMC8198655. doi:10.3390/cancers13112648
   PubMed Web of Science ®Google Scholar
• Caspary WF, Reimold WV. Klinische bedeutung des 14C-glykocholat-atemtests in der gastroenterologischen diagnostik bei erkrankungen mit gesteigerter dekonjugation von Gallensäuren [clinical significance of the 14C-glycocholate breath test in the diagnosis of gastro-enterological diseases (author’s transl)]. Dtsch Med Wochenschr. 1976. 101(10):353–360. German. PMID: 1248374. doi:10.1055/s-0028-1104088
   PubMed Web of Science ®Google Scholar
• Baumgartner U, Schölmerich J, Kremer B, et al. Early detection of graft dysfunction after orthotopic liver transplantation in man by serum and biliary bile acid analysis. Hepatogastroenterology. 1995;42(6):950–960. PMID: 8847051.
   PubMedGoogle Scholar
• Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis. 2004;8(1):67–81. PMID: 15062194. doi:10.1016/S1089-3261(03)00135-1
   PubMedGoogle Scholar
• Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525–531. PMID: 12198643. doi:10.1053/jhep.2002.36088
   PubMed Web of Science ®Google Scholar
• Tint GS, Salen G, Colalillo A, et al. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med. 1982;97(3):351–356. PMID: 7051912. doi:10.7326/0003-4819-97-3-351
   PubMed Web of Science ®Google Scholar
• Novotny K, Hapshy V, Nguyen H, Parmar M. Obeticholic acid. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 33620812.
   Google Scholar
• Kjærgaard K, Frisch K, Sørensen M, et al. Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. J Hepatol. 2021;74(1):58–65. PMID: 32717289. doi:10.1016/j.jhep.2020.07.028
   PubMed Web of Science ®Google Scholar
• Insull W Jr. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. South Med J. 2006;99(3):257–273. PMID: 16553100. doi:10.1097/01.smj.0000208120.73327.db
   PubMed Web of Science ®Google Scholar
• Lee KJ. Pharmacologic agents for chronic diarrhea. Intest Res. 2015;13(4):306–312. PMID: 26576135; PMCID: PMC4641856. doi:10.5217/ir.2015.13.4.306
   PubMedGoogle Scholar
• Al-Dury S, Marschall HU. Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH. Front Pharmacol. 2018;9:931. PMID: 30186169; PMCID: PMC6111463. doi:10.3389/fphar.2018.00931
   PubMed Web of Science ®Google Scholar
• Rao A, Kosters A, Mells JE, et al. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice. Sci Transl Med. 2016;8(357):357ra122. PMID: 27655848; PMCID: PMC5056562. doi:10.1126/scitranslmed.aaf4823
   PubMed Web of Science ®Google Scholar
• Chedid V, Vijayvargiya P, Camilleri M. Elobixibat for the treatment of constipation. Expert Rev Gastroenterol Hepatol. 2018;12(10):951–960. PMID: 30204504; PMCID: PMC6386599. doi:10.1080/17474124.2018.1522248
   PubMed Web of Science ®Google Scholar
• Halpern MD, Weitkamp JH, Mount Patrick SK, et al. Apical sodium-dependent bile acid transporter upregulation is associated with necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):G623–31. PMID: 20616306; PMCID: PMC2950692. doi:10.1152/ajpgi.00242.2010
   PubMed Web of Science ®Google Scholar
• Saveleva EE, Tyutrina ES, Nakanishi T, Tamai I, Salmina AB. Ingibitory natriĭ-zavisimogo perenoschika zhelchnykh kislot (ASBT) kak perspektivnye lekarstvennye sredstva [The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs]. Biomed Khim. 2020. 66(3):185–195. Russian. PMID: 32588824. doi:10.18097/PBMC20206603185
   PubMedGoogle Scholar
• Agarwal S, Patil A, Aware U, et al. Discovery of a potent and orally efficacious TGR5 receptor agonist. ACS Med Chem Lett. 2015;7(1):51–55. PMID: 26819665; PMCID: PMC4716599. doi:10.1021/acsmedchemlett.5b00323
   PubMed Web of Science ®Google Scholar
• Hodge RJ, Nunez DJ. Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype? Diabetes Obes Metab. 2016;18(5):439–443. PMID: 26818602. doi:10.1111/dom.12636
   PubMed Web of Science ®Google Scholar
• Zhou M, Learned RM, Rossi SJ, DePaoli AM, Tian H, Ling L. Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. Hepatol Commun. 2017;1(10):1024–1042. PMID: 29404440; PMCID: PMC5721409. doi:10.1002/hep4.1108
   PubMed Web of Science ®Google Scholar
• Moon B, Kim MC, Park JS. Synthetic CDCA derivatives-induced apoptosis of stomach cancer cell line SNU-1 cells. Cancer Res Treat. 2004;36(2):132–139. PMID: 20396553; PMCID: PMC2855097. doi:10.4143/crt.2004.36.2.132
   PubMedGoogle Scholar
• Xu M, Zhao Q, Shao D, Liu H, Qi J, Qin C. Chenodeoxycholic acid derivative HS-1200 inhibits hepatocarcinogenesis and improves liver function in diethylnitrosamine-exposed rats by downregulating MTH1. Biomed Res Int. 2017;2017:1465912. PMID: 28261604; PMCID: PMC5316462. doi:10.1155/2017/1465912
   PubMed Web of Science ®Google Scholar
• Im EO, Choi YH, Paik KJ, et al. Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett. 2001;163(1):83–93. PMID: 11163111. doi:10.1016/s0304-3835(00)00671-6
   PubMed Web of Science ®Google Scholar
• Šarenac T, Mikov M. Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 2019;10:484. PMID: 31214018; PMCID: PMC6558109. doi:10.3389/fphar.2019.00484
   PubMed Web of Science ®Google Scholar
• Choi YH, Im EO, Suh H, Jin Y, Yoo YH, Kim ND. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett. 2003;199(2):157–167. PMID: 12969788. doi:10.1016/s0304-3835(03)00351-3
   PubMed Web of Science ®Google Scholar
• Choi YH, Im EO, Suh H, et al. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int J Oncol. 2001;18(5):979–984. PMID: 11295044. doi:10.3892/ijo.18.5.979
   PubMed Web of Science ®Google Scholar
• Pavlović N, Goločorbin-Kon S, Ðanić M, et al. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Front Pharmacol. 2018;9:1283. PMID: 30467479; PMCID: PMC6237018. doi:10.3389/fphar.2018.01283
   PubMed Web of Science ®Google Scholar
• Nurunnabi M, Khatun Z, Revuri V, et al. Design and strategies for bile acid mediated therapy and imaging. RSC Adv. 2016;6(78):73986–74002. doi:10.1039/C6RA10978K
   Web of Science ®Google Scholar
• Ziv E, Eldor A, Kleinman Y, Bar-On H, Kidron M. Bile salts facilitate the absorption of heparin from the intestine. Biochem Pharmacol. 1983;32(5):773–776. PMID: 6838625. doi:10.1016/0006-2952(83)90575-0
   PubMed Web of Science ®Google Scholar